Literature DB >> 2987403

Recognition of mos-related proteins with an antiserum to a peptide of the v-mos gene product.

G E Gallick, J T Sparrow, B Singh, S A Maxwell, L H Stanker, R B Arlinghaus.   

Abstract

A mos-specific antiserum was generated by injection of rabbits with a peptide predicted from the sequence of the v-mos gene of Moloney murine sarcoma virus (MuSV) strain 124. The peptide is composed of amino acids 37-55 (cyclized at the cysteine residues) conjugated to keyhole limpet haemocyanin. This serum [anti-mos(37-55c)] specifically recognized p37mos in MuSV-124 acutely infected NIH-3T3 cells, P85gag-mos in 6m2 cells, an NRK clone infected with the temperature-sensitive mutant (ts110) of Moloney MuSV, and P100gag-mos in 54-5A4 cells, an NRK clone infected with a spontaneous revertant of ts110. An additional protein of Mr 55000 from uninfected cells was recognized by this serum. Reactivity of the serum toward the v-mos-containing proteins and the 55K protein was completely inhibited by prior incubation with free peptide. The 55K protein was not recognized by antisera made from synthetic peptides prepared from the C-terminal eight or 12 amino acids of v-mos.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2987403     DOI: 10.1099/0022-1317-66-5-945

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  11 in total

1.  Transforming mutant v-mos protein kinases that are deficient in in vitro autophosphorylation.

Authors:  R S Freeman; D J Donoghue
Journal:  Mol Cell Biol       Date:  1989-09       Impact factor: 4.272

2.  Reversion of thermosensitive splicing defect of Moloney murine sarcoma virus ts110 by oversplicing of viral RNA.

Authors:  R Hamelin; N Honore; D Sergiescu; B Singh; J Gerfaux; R B Arlinghaus
Journal:  J Virol       Date:  1990-03       Impact factor: 5.103

3.  v-mos protein produced by in vitro translation has protein kinase activity.

Authors:  N K Herzog; M Nash; L S Ramagli; R B Arlinghaus
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

4.  The P55 protein affected by v-mos expression is vimentin.

Authors:  B Singh; R Goldman; L Hutton; N K Herzog; R B Arlinghaus
Journal:  J Virol       Date:  1987-11       Impact factor: 5.103

5.  Use of site-specific antipeptide antibodies to perturb the serine kinase catalytic activity of p37mos.

Authors:  S A Maxwell; R B Arlinghaus
Journal:  J Virol       Date:  1985-09       Impact factor: 5.103

6.  p37mos-associated serine/threonine protein kinase activity correlates with the cellular transformation function of v-mos.

Authors:  B Singh; M Hannink; D J Donoghue; R B Arlinghaus
Journal:  J Virol       Date:  1986-12       Impact factor: 5.103

7.  Inhibition of v-Mos kinase activity by protein kinase A.

Authors:  Y Yang; C H Herrmann; R B Arlinghaus; B Singh
Journal:  Mol Cell Biol       Date:  1996-03       Impact factor: 4.272

8.  Temperature-sensitive splicing defect of ts110 Moloney murine sarcoma virus is virus encoded.

Authors:  R Hamelin; K Kabat; D Blair; R B Arlinghaus
Journal:  J Virol       Date:  1986-01       Impact factor: 5.103

9.  Expression of the v-mos gene alters a Mr 55,000 protein during acute infection by Moloney murine sarcoma virus.

Authors:  B Singh; J T Sparrow; A M Hedge; R B Arlinghaus
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

10.  v-mos proteins encoded by myeloproliferative sarcoma virus and its ts159 mutant.

Authors:  B Singh; C Stocking; R Walker; Y D Yang; W Ostertag; R B Arlinghaus
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.